Teva and AbCellera team up to discover monoclonal antibodies
3 February 2016 | By Victoria White
AbCellera will apply its high-throughput single cell antibody platform for the discovery of the rare monoclonal antibodies...
List view / Grid view
News
Adaptimmune and GSK expand cancer immunotherapy collaboration
3 February 2016 | By Victoria White
The enhanced agreement will accelerate Adaptimmune’s lead clinical cancer programme, an affinity enhanced T-cell immunotherapy targeting NY-ESO-1...
Leicester’s Dr Echalier awarded Domainex’s Discovery STAR AWARD
3 February 2016 | By Victoria White
This award will give Dr Echalier access to the drug discovery capabilities of Domainex in support of her research...
MISSION Therapeutics raises £60m to advance DUB inhibitors
2 February 2016 | By Victoria White
The £60 million enables the company to maximise the potential of its DUB platform and advance a series of DUB inhibitors...
Non-coding RNA helps suppress breast cancer
2 February 2016 | By Victoria White
A team of scientists from Bath, Cambridge and the USA has identified a piece of non-coding RNA that stops cells turning cancerous...
Cell Therapy Catapult becomes Cell and Gene Therapy Catapult
2 February 2016 | By Victoria White
The Cell Therapy Catapult has changed its name to the Cell and Gene Therapy Catapult to more accurately reflect the activities of the organisation...
HFEA approves embryo gene editing
1 February 2016 | By Victoria White
The aim of the research is to understand the genes human embryos need to develop successfully...
Stem cells that can repair the skull and face bones
1 February 2016 | By Victoria White
Scientists have, for the first time, identified and isolated stem cells capable of skull formation and craniofacial bone repair in mice...
Astellas and CLINO team up for retinitis pigmentosa gene therapy
1 February 2016 | By Victoria White
Astellas and CLINO have entered into a license agreement for the worldwide development and commercialisation of Adeno-associated Virus-modified Volvox channelrhodopsin-1 (AAV-mVChR1)...
Nordic Nanovector awarded grant to develop novel therapeutics
1 February 2016 | By Victoria White
Nordic Nanovector has been awarded the NOK 15 million grant from the Research Council of Norway’s User-driven Research-based Innovation programme...
Epigenome mining leads to medulloblastoma discovery
29 January 2016 | By Victoria White
Researchers have identified the cells that likely give rise to the brain tumour subtype Group 4 medulloblastoma, removing a barrier to developing more effective targeted therapies....
Pfizer to give a keynote address on reviving covalent drug design in oncology at SMi’s 15th annual event this February
29 January 2016 | By SMi Group
SMi group reports: Doug Johnson, Research Fellow at Pfizer will be giving a keynote address on Day 1 at the SMi’s 15th annual Advances and Progress in Drug Design conference...
ADC Summit 2016 to highlight the developments for next wave of antibody-drug conjugates
29 January 2016 | By SMi Group
Registration now live for the 5th annual ADC Summit taking place at the Holiday Inn Kensington Forum, London, UK on the 23rd – 24th May 2016...
New therapy halts progression of ALS in mice
29 January 2016 | By Victoria White
Researchers have announced that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS) for nearly two years in one type of mouse model...
Karolinska Institutet and Biovica to evaluate promising cancer treatments
29 January 2016 | By Victoria White
The lab headed by Thomas Helleday at Karolinska Institutet and Biovica are to collaborate to improve evaluation of new, promising cancer therapies...
